Medical Advisory Board The MDS Foundation is privileged to have such a select group of physicians dedicated to the identification, classification and treatment of the Myelodysplastic Syndromes. This International Advisory Board is dedicated to ensuring that the most current information is presented in a variety of formats to enhance the educational experience. Chairman John M. Bennett, MD Professor of Oncology Medicine, Laboratory Medicine and Pathology, Emeritus University of Rochester Rochester, New York USA Advisory Board Members   Eva Hellström-Lindberg, MD, PhD Associate Professor Karolinska Institute Institution for Medicine Huddinge University Hospital Stockholm, Sweden Alan F. List, MD Professor of Medicine University of South Florida and Director, Hematologic Malignancies Program H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida USA G.J. Mufti, MD Professor of Medicine School of Medicine and Dentistry of King's College London London, England, UK Charlotte M. Niemeyer, MD Professor of Pediatrics University Children's Hospital Freiburg, Germany Stephen D. Nimer, MD Head, Division of Hematologic Oncology Memorial Sloan-Kettering Cancer Center New York, New York USA David T. Bowen, MD Consultant Haematologist The Leeds Teaching Hospitals Leeds General Infirmary Leeds, Scotland Theo J.M. de Witte, MD, PhD University of Nijmegen University Hospital st. Radboud Nijmegen, The Netherlands Pierre Fenaux, MD Professor of Hematology Hôpital Avicenne University Paris 13 Bobigny, France Peter L. Greenberg, MD Professor of Medicine and Hematology Stanford University School of Medicine Stanford, California USA Terry Hamblin, DM, FRCP, FRC Path Professor of Immunohaematology Southhampton University Bournemouth, England, UK